Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a
complex disorder with an unknown cause. However, the dysbiosis of the gut microbiome has …

The discovery of natural products has been pivotal in drug development, providing a vast
reservoir of bioactive compounds from various biological sources. This narrative review …

Background Triphala (TLP), as a Chinese Tibetan medicine composing of Emblica
officinalis, Terminalia chebula and Terminalia bellirica (1.2: 1.5: 1), exhibited …

The objective of the current research is to develop ZnO-Manjistha extract (ZnO-MJE)
nanoparticles (NPs) and to investigate their transdermal delivery as well as antimicrobial …

Vascular anomalies (VA) are developmental anomalies of veins, arteries, lymphatics or
capillaries thought to be caused by mutations in genes that drive angiogenesis. Treatments …

The emerging role of gut-brain axis decoding recently created a new hope for investigating
the biological and physiological basis of neurodegenerative disorders and other …

Scope Akkermansia muciniphila (A. muciniphila) are Gram negative commensal bacteria,
degrading mucin in the intestinal mucosa, modulating intestinal permeability and …

Parkinson's disease (PD) is a neurodegenerative disease characterized by the loss of
dopaminergic neurons. Although the etiology of PD remains elusive, it has been …

Background: The Indian Ayurvedic herbal formula Triphala (TPL) is known for its
pharmacological properties for immunomodulation, anti-inflammation, antioxidant, and anti …

Triphala is a mixture of tree fruits obtained from Terminalia chebula, Terminalia bellerica,
and Phyllanthus emblica. It is one of the Ayurveda medicinal recipes used to treat health …